Back

PDBEB Courses 2020/2021 - Drug development

Organized by

Without Information

Date & Time

17/05/2021 - 28/05/2021

Registation

No mandatory

Lectures

No results

Aim

May 17 - 28
Coordinators: João Nuno Moreira - jmoreira@ff.uc.pt & Luís Almeida - luispa@cnc.uc.pt

Program

May 17 - Monday

10.30 h - Introduction to the course
João Nuno Moreira - PhD (CNC and Faculty of Pharmacy, University of Coimbra)
Luís Pereira de Almeida - PhD (CNC and Faculty of Pharmacy, University of Coimbra)
Sérgio Simões - PhD (CNC and Faculty of Pharmacy, University of Coimbra)
Stan N. Finkelstein - MD, PhD (Senior Research Assistant in the MIT Engineering Systems Division and Associate Professor of Medicine at Harvard Medical School)

16:00 h - Re-Engineering the Drug Business
Robert Mulroy - Chairman and CEO of Partners Therapeutics, Inc


May 18 - Tuesday

10.30 h - Translational cancer nanomedicine: from a FCT-funded project to drug development
João Nuno Moreira - PhD (CNC and Faculty of Pharmacy, University of Coimbra)

15.00 h - Evolving economics of the pharmaceutical industry
Stan N. Finkelstein - MD, PhD (Senior Research Scientist in the MIT Engineering Systems Division and Associate Professor of Medicine, Harvard Medical School)


May 19 - Wednesday

10.00 h - Modeling chemistry and biology in drug discovery
Marco Neves - PhD (BIAL, Indústria Farmacêutica, Portugal)



11.30 h - Development of small molecule inhibitors for treatment of CNS disorders
Laszlo Kiss - PhD (BIAL, Indústria Farmacêutica, Portugal)



14.30 h - Pharmacology and toxicology of new chemical entities
Nuno M. Pires - PhD (BIAL, Indústria Farmacêutica, Portugal)


16:00 h - Clinical development of new chemical entities
Joana Moreira - Pharm D (BIAL, Indústria Farmacêutica, Portugal)


May 20 - Thursday

10.00 h - Some issues in drug development: discussion of case studies
Miguel Prazeres - PhD (Instituto Superior Técnico, Technical University of Lisbon)

15.00 h - FDA Process, Off-Label Prescribing, Insurance Coverage
Stan N. Finkelstein - MD, PhD (Senior Research Assistant in the MIT Engineering Systems Division and Associate Professor of Medicine at Harvard Medical School)


May 21 - Friday

9.00 h - Bluepharma Pharmaceutical Industry SA: from development of generics to innovative research: virtual visit
Sérgio Simões - PhD

14.00 h - New non-viral options for therapeutic delivery
Koen Breyne - PhD (Department of Neurology, Massachusetts General Hospital, Harvard Medical School)


May 24 – Monday

10.00 h - Gene and Cell therapy Medicinal Products
Luís Pereira de Almeida - PhD (CNC)
Rui Nobre - PhD (CNC)
Liliana Mendonça - PhD (CNC)
Magda Santana - PhD (CNC)


16.00 h - The Quest for Better Treatments: Drug Development and Regulatory Challenges
Bruno Sepodes - PhD (Universidade de Lisboa (Portugal) / European Medicines Agency (EMA))

18.00 h - Global regulation and reliance: from medicinal products to integrated health technologies
Rogério Gaspar – PhD (Director, Department of Regulation and Prequalification, WHO, Geneva)


May 25 - Tuesday

10.00 h - Molecular Imaging and Drug Development
Antero Abrunhosa - PhD (Instituto de Ciências Nucleares Aplicadas à Saúde - ICNAS);

16.00 h - Translational insights into clinical trials: application of molecular and cellular data to understand efficacy in patient segments
Daniel Lopes de Menezes - BPharm, MScPharm, PhD (Associate Director, Late-Stage Translational Development, Celgene)


May 26 - Wednesday

16.00 h - Drug Discovery and Development at PTC Therapeutics: Small Molecules to Gene Therapy
Amal Dakka - PhD (Director External Innovations & Alliance Management at PTC Therapeutics, Inc.)


May 27 - Thursday
10.00 h - Dry Powder Inhalation Solutions.
Cláudia Moura - PhD (Senior Scientist, Oral Process Development Group, Hovione)


May 28 - Friday
09.30 h - Students presentations

Documents

We use cookies to improve your visit to our website.